← All diseases Cancer

Lung cancer (non-small cell)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the toughest evidence (186)Meta-analysis (67)Treatment guideline (1)Randomized trial (51)Systematic review (38)Phase 3 study (29)Clinical Research (661)Review article (246)Early Study (Phase 1 or 2) (77)Case report (126)Laboratory or animal research (69)Commentary or Editorial (87)Retracted publication (14) Only studies that are currently seeking participants (78)

Filter

Publications and studies (3237)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer. (2020/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Impact of Age on Inflammation-Based Scores among Patients Diagnosed with Stage III Non-Small Cell Lung Cancer. (2020/01/01) ♡
• Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immune-related organizing pneumonitis in non-small cell lung cancer receiving PD-1 inhibitor treatment: A case report and literature review. (2020/01/01) ♡
• Comparison of I(125) seed brachytherapy (radioactive seed brachytherapy) joint three-dimensional conformal radiotherapy and stereotactic ablative radiotherapy on early nonsmall cell lung cancer. (2020/01/01) ♡
• Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer. (2020/01/01) ♡
• The association between fibroblast growth factor receptor 1 gene amplification and lung cancer: a meta-analysis. (2019/12/31) ♡
• Expression and Effects of Long Non-Coding RNA, LINC01124, in Non-Small Cell Lung Cancer. (2019/12/31) ♡
• Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1. (2019/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunotherapy for the Treatment of Breast Cancer: Emerging New Data. (2019/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: Emerging Mechanisms and Perspectives. (2019/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer. (2019/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epigenetic roles of PIWI proteins and piRNAs in lung cancer. (2019/12/21) ♡
• 5-Aminolevulinic Acid Fluorescence Indicates Perilesional Brain Infiltration in Brain Metastases. (2019/12/16) ♡
• Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway. (2019/12/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rebiopsy with Thoracoscopy under Local Anesthesia for the Detection of EGFR T790M Mutation. (2019/12/09) ♡
• Development and Evaluation of Paclitaxel-Loaded Aerosol Nanocomposite Microparticles and Their Efficacy Against Air-Grown Lung Cancer Tumor Spheroids. (2019/12/09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study. (2019/12/02) ♡
• In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer. (2019/12/01) ♡
• Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines. (2019/12/01) ♡
• Ursolic acid promotes apoptosis and mediates transcriptional suppression of CT45A2 gene expression in non-small-cell lung carcinoma harbouring EGFR T790M mutations. (2019/12/01) ♡
• Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer. (2019/12/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Cancer cachexia in thoracic malignancy: a narrative review. (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Exploring the dietary protein intake and skeletal muscle during first-line anti-neoplastic treatment in patients with non-small cell lung cancer. (2019/12/01) ♡
• Comparison of next-generation sequencing and immunohistochemistry analysis for targeted therapy-related genomic status in lung cancer patients. (2019/12/01) ♡
• Patterns of diagnostic procedures for lung cancer pathology in the Middle East and North Africa. (2019/12/01) ♡
• Prognostic factors in stage IB non-small cell lung cancer according to the 8th edition of the TNM staging system after curative resection. (2019/12/01) ♡
• Dynamics of coagulation factor XIII activity after video-assisted thoracoscopic lobectomy for non-small cell lung cancer. (2019/12/01) ♡
• A nomogram to predict overall survival of patients with early stage non-small cell lung cancer. (2019/12/01) ♡
• Surgical outcomes of stage IV non-small cell lung cancer: a single-center experience. (2019/12/01) ♡
• Extended resections for the treatment of patients with T4 stage IIIA non-small cell lung cancer (NSCLC) (T4N0-1M0) with or without cardiopulmonary bypass: a 15-year two-center experience. (2019/12/01) ♡
• Identification of potential microRNAs and their targets in promoting gefitinib resistance by integrative network analysis. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. A first attempt to establish a definition of oligometastatic non-small cell lung cancer by a European consensus group. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Neoadjuvant versus adjuvant chemotherapy for resectable non-small cell lung cancer debate revisited. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Local consolidative therapy for oligometastatic non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. What is synchronous oligometastatic non-small cell lung cancer? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Neoadjuvant vs. adjuvant chemotherapy in locally advanced non-small cell lung cancer-is timing everything? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Targeted next-generation sequencing to assess tumor mutation burden: ready for prime-time in non-small cell lung cancer? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Is first-line pembrolizumab appropriate for all patients with metastatic non-squamous histology non-small cell lung cancer patients? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Looking for the high way in EGFR-positive non-small cell lung cancer through the evaluation of survival endpoints. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Is the game over for PD-1 inhibitors in EGFR mutant non-small cell lung cancer? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Surveillance imaging for non-small cell lung cancer: mounting evidence that less is more. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of surveillance frequency on survival in non-small cell lung cancer (NSCLC) survivors. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Broad-based genomic sequencing in advanced non-small cell lung cancer in the dock. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Erlotinib as standard adjuvant therapy for resectable EGFR mutation-positive non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Lorlatinib: an additional option for ALK-positive non-small cell lung cancer? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach. (2019/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.